68Ga-Pentixafor PET/CT demonstrating higher CXCR4 density in small cell lung carcinoma than in non-small cell variant

被引：0
|
作者：
Ankit Watts
Baljinder Singh
Rajender Basher
Harmandeep Singh
Amanjit Bal
Rakesh Kapoor
Sunil K. Arora
Hans J. Wester
B. R. Mittal
D. Behera
机构：
[1] Postgraduate Institute of Medical Education and Research,
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2017年 / 44卷
关键词：
CXCR4 Expression; Small Cell Lung Carcinoma; Lung Mass; Maximum Fluorescence Intensity; Significant CXCR4;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：909 / 910
页数：1
相关论文
共 50 条
  • [31] Non-invasive evaluation of CXCR4 expression of MALT lymphoma using 68Ga-Pentixafor PET/MRI- a prospective study
    Leisser, Asha
    Mayerhofer, Marius
    Raderer, Markus
    Wadsak, Wolfgang
    Mitterhauser, Markus
    Pfaff, Sarah
    Kropf, Saskia
    Wester, Hans
    Hacker, Marcus
    Hartenbach, Markus
    Haug, Alexander
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [32] Determination of chemokine receptor CXCR4 by 68-Ga-Pentixafor PET in patients with adrenocortical carcinoma
    Bluemel, C.
    Hahner, S.
    Heinze, B.
    Schirbel, A.
    Schottelius, M.
    Lapa, C.
    Kropf, S.
    Lueckerath, K.
    Allolio, B.
    Fassnacht, M.
    Wester, H.
    Buck, A. K.
    Herrmann, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S223 - S224
  • [33] Assessment of Central Nervous System Lymphoma Based on CXCR4 Expression In Vivo Using 68Ga-Pentixafor PET/MRI
    Starzer, Angelika M.
    Berghoff, Anna S.
    Traub-Weidinger, Tatjana
    Haug, Alexander R.
    Widhalm, Georg
    Hacker, Marcus
    Rausch, Ivo
    Preusser, Matthias
    Mayerhoefer, Marius E.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (01) : 16 - 20
  • [34] Chemokine Receptor 4-Targeted PET/CT With 68Ga-Pentixather Detects More Lesions Than 68Ga-Pentixafor PET/CT in Multiple Myeloma
    Yang, Qiao
    Zhang, Fujing
    Hao, Zhixin
    Zhuang, Junling
    Huo, Li
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : 592 - 593
  • [35] Imaging Inflammation in Atherosclerosis with CXCR4-directed 68Ga-Pentixafor PET/CT - Correlation with 18F-FDG PET/CT
    Kircher, Malte
    Li, Xiang
    Kemmer, Luisa
    Schirbel, Andreas
    Buck, Andreas
    Wester, Hans
    Hacker, Marcus
    Lapa, Constantin
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [36] [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer - initial experience
    Lapa, Constantin
    Lueckerath, Katharina
    Rudelius, Martina
    Schmid, Jan-Stefan
    Schoene, Alexander
    Schirbel, Andreas
    Samnick, Samuel
    Pelzer, Theo
    Buck, Andreas K.
    Kropf, Saskia
    Wester, Hans-Juergen
    Herrmann, Ken
    ONCOTARGET, 2016, 7 (08) : 9288 - 9295
  • [37] [68Ga]-Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer - initial experience
    Lapa, Constantin
    Lueckerath, Katharina
    Rudelius, Martina
    Schirbel, Andreas
    Samnick, Samuel
    Pelzer, Theo
    Buck, Andreas
    Kropf, Saskia
    Wester, Hans-Juergen
    Herrmann, Ken
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [38] Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma
    Dragoj, Miodrag
    Milosevic, Zorica
    Bankovic, Jasna
    Tanic, Nikola
    Pesic, Milica
    Stankovic, Tijana
    CELLULAR ONCOLOGY, 2017, 40 (01) : 47 - 62
  • [39] Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma
    Miodrag Dragoj
    Zorica Milosevic
    Jasna Bankovic
    Nikola Tanic
    Milica Pesic
    Tijana Stankovic
    Cellular Oncology, 2017, 40 : 47 - 62
  • [40] Imaging Inflammation in Atherosclerosis with CXCR4-Directed 68Ga-Pentixafor PET/CT: Correlation with 18F-FDG PET/CT
    Kircher, Malte
    Tran-Gia, Johannes
    Kemmer, Luisa
    Zhang, Xiaoli
    Schirbel, Andreas
    Werner, Rudolf A.
    Buck, Andreas K.
    Wester, Hans-Juergen
    Hacker, Marcus
    Lapa, Constantin
    Li, Xiang
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (05) : 751 - 756
12345